$MYG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Mirati Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Mirati Therapeutics, Inc.. Get notifications about new insider transactions in Mirati Therapeutics, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22 2018 | MYG | Mirati Therapeutic ... | Reisman Neil | Option Exercise | A | 27.00 | 10,000 | 270,000 | 10,000 | ||
| Jan 22 2018 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Option Exercise | A | 27.00 | 50,000 | 1,350,000 | 50,000 | |
| Jan 18 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Option Exercise | M | 17.41 | 10,814 | 188,272 | 33,936 | |
| Jan 18 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Sell | S | 27.00 | 10,814 | 291,978 | 2,877 | 13.7 K to 2.9 K (-78.99 %) |
| Jan 18 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Buy | M | 17.41 | 10,814 | 188,272 | 13,691 | 2.9 K to 13.7 K (+375.88 %) |
| Jan 11 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Option Exercise | M | 17.41 | 10,500 | 182,805 | 44,750 | |
| Jan 11 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Option Exercise | M | 8.50 | 4,000 | 34,000 | 0 | |
| Jan 11 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Sell | S | 23.00 | 14,500 | 333,526 | 2,877 | 17.4 K to 2.9 K (-83.44 %) |
| Jan 11 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Sell | S | 22.00 | 225 | 4,950 | 16,670 | 16.9 K to 16.7 K (-1.33 %) |
| Jan 11 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Buy | M | 17.41 | 10,500 | 182,805 | 16,895 | 6.4 K to 16.9 K (+164.19 %) |
| Jan 11 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Buy | M | 8.50 | 4,000 | 34,000 | 6,395 | 2.4 K to 6.4 K (+167.01 %) |
| Nov 22 2017 | MYG | Mirati Therapeutic ... | Tuesday Thirteen Inc. | 10% Owner | Sell | S | 10.65 | 1,000 | 10,650 | 0 | 1,000 to 0 (-100.00 %) |
| Nov 20 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | Option Exercise | P | 0.00 | 1,618,684 | 1,619 | 1,618,684 | ||
| Nov 20 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | Option Exercise | P | 0.00 | 304,392 | 304 | 304,392 | ||
| Nov 20 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | P | 0.00 | 1,413,475 | 1,413 | 1,413,475 | |
| Nov 20 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | P | 0.00 | 801,448 | 801 | 801,448 | |
| Nov 20 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | P | 13.00 | 255,264 | 3,318,432 | 3,135,966 | 2.9 M to 3.1 M (+8.86 %) |
| Nov 20 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | P | 13.00 | 144,736 | 1,881,568 | 1,372,510 | 1.2 M to 1.4 M (+11.79 %) |
| Nov 20 2017 | MYG | Mirati Therapeutic ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 18.05 | 60,000 | 1,083,000 | 2,728,601 | 2.8 M to 2.7 M (-2.15 %) |
| Nov 17 2017 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Option Exercise | M | 8.50 | 10,000 | 85,000 | 4,000 | |
| Nov 17 2017 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Sell | S | 18.00 | 10,275 | 184,950 | 2,395 | 12.7 K to 2.4 K (-81.10 %) |
| Nov 17 2017 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Buy | M | 8.50 | 10,000 | 85,000 | 12,670 | 2.7 K to 12.7 K (+374.53 %) |
| Nov 16 2017 | MYG | Mirati Therapeutic ... | venBio Select Advisor LLC | 10% Owner | Option Exercise | X | 7.86 | 37,500 | 294,750 | 0 | |
| Nov 16 2017 | MYG | Mirati Therapeutic ... | venBio Select Advisor LLC | 10% Owner | Buy | X | 7.86 | 37,500 | 294,750 | 4,398,101 | 4.4 M to 4.4 M (+0.86 %) |
| Nov 16 2017 | MYG | Mirati Therapeutic ... | venBio Select Advisor LLC | 10% Owner | Buy | P | 13.00 | 650,000 | 8,450,000 | 4,360,601 | 3.7 M to 4.4 M (+17.52 %) |
| Nov 13 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 7.86 | 5,996 | 47,129 | 0 | |
| Nov 13 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 7.86 | 249,801 | 1,963,436 | 0 | |
| Nov 13 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 7.86 | 24,466 | 192,303 | 0 | |
| Nov 13 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 7.86 | 5,996 | 47,129 | 35,999 | 30 K to 36 K (+19.98 %) |
| Nov 13 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 7.86 | 249,801 | 1,963,436 | 2,372,218 | 2.1 M to 2.4 M (+11.77 %) |
| Nov 13 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 7.86 | 24,466 | 192,303 | 141,244 | 116.8 K to 141.2 K (+20.95 %) |
| Nov 03 2017 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Option Exercise | M | 5.50 | 7,499 | 41,245 | 22,501 | |
| Nov 03 2017 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Sell | S | 14.00 | 7,499 | 104,986 | 2,670 | 10.2 K to 2.7 K (-73.74 %) |
| Nov 03 2017 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Buy | M | 5.50 | 7,499 | 41,245 | 10,169 | 2.7 K to 10.2 K (+280.86 %) |
| Oct 06 2017 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Option Exercise | M | 8.50 | 4,000 | 34,000 | 0 | |
| Oct 06 2017 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Sell | S | 14.00 | 4,000 | 56,000 | 2,670 | 6.7 K to 2.7 K (-59.97 %) |
| Oct 06 2017 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Buy | M | 8.50 | 4,000 | 34,000 | 6,670 | 2.7 K to 6.7 K (+149.81 %) |
| Oct 03 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | X | 7.86 | 78,186 | 614,542 | 0 | |
| Oct 03 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | X | 7.86 | 189,780 | 1,491,671 | 0 | |
| Oct 03 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | X | 7.86 | 78,186 | 614,542 | 513,630 | 435.4 K to 513.6 K (+17.96 %) |
| Oct 03 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | X | 7.86 | 189,780 | 1,491,671 | 1,227,774 | 1 M to 1.2 M (+18.28 %) |
| Oct 03 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | X | 7.86 | 78,186 | 614,542 | 0 | |
| Oct 03 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | X | 7.86 | 189,780 | 1,491,671 | 0 | |
| Oct 03 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | X | 7.86 | 78,186 | 614,542 | 513,630 | 435.4 K to 513.6 K (+17.96 %) |
| Oct 03 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | X | 7.86 | 189,780 | 1,491,671 | 1,227,774 | 1 M to 1.2 M (+18.28 %) |
| Sep 18 2017 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Sell | S | 12.00 | 770 | 9,240 | 2,670 | 3.4 K to 2.7 K (-22.38 %) |
| Jun 26 2017 | MYG | Mirati Therapeutic ... | Reisman Neil | Director | Option Exercise | A | 4.05 | 25,000 | 101,250 | 25,000 | |
| May 19 2017 | MYG | Mirati Therapeutic ... | LAPPE RODNEY W | Director | Option Exercise | A | 3.65 | 15,000 | 54,750 | 15,000 | |
| May 19 2017 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Director | Option Exercise | A | 3.65 | 10,000 | 36,500 | 10,000 | |
| May 19 2017 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Director | Option Exercise | A | 3.65 | 10,000 | 36,500 | 10,000 | |
| May 19 2017 | MYG | Mirati Therapeutic ... | Johnson Craig A | Director | Option Exercise | A | 3.65 | 10,000 | 36,500 | 10,000 | |
| May 19 2017 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Director | Option Exercise | A | 3.65 | 10,000 | 36,500 | 10,000 | |
| May 11 2017 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 8.49 | 167,204 | 1,419,562 | 167,204 | |
| May 11 2017 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | D | 8.49 | 167,204 | 1,419,562 | 0 | |
| Apr 03 2017 | MYG | Mirati Therapeutic ... | LAPPE RODNEY W | Director | Option Exercise | A | 5.15 | 5,000 | 25,750 | 5,000 | |
| Jan 30 2017 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Option Exercise | A | 5.40 | 50,000 | 270,000 | 50,000 | |
| Jan 30 2017 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 5.40 | 110,000 | 594,000 | 110,000 | |
| Jan 30 2017 | MYG | Mirati Therapeutic ... | CHEN ISAN | Sr. VP, Chief Medic ... | Option Exercise | A | 5.40 | 50,000 | 270,000 | 50,000 | |
| Jan 30 2017 | MYG | Mirati Therapeutic ... | LEMASTERS CHRISTOPHER C. | EVP, Chief Business ... | Option Exercise | A | 5.40 | 11,250 | 60,750 | 11,250 | |
| Jan 30 2017 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Option Exercise | A | 5.40 | 50,000 | 270,000 | 50,000 | |
| Jan 30 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.45 | 28,839 | 157,173 | 2,880,702 | 2.9 M to 2.9 M (+1.01 %) |
| Jan 30 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.44 | 19,330 | 105,155 | 2,851,863 | 2.8 M to 2.9 M (+0.68 %) |
| Jan 25 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.42 | 30,600 | 165,852 | 2,832,533 | 2.8 M to 2.8 M (+1.09 %) |
| Jan 25 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.32 | 27,682 | 147,268 | 2,801,933 | 2.8 M to 2.8 M (+1.00 %) |
| Jan 25 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.27 | 19,251 | 101,453 | 2,774,251 | 2.8 M to 2.8 M (+0.70 %) |
| Jan 20 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.42 | 23,873 | 129,392 | 2,755,000 | 2.7 M to 2.8 M (+0.87 %) |
| Jan 20 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.48 | 21,085 | 115,546 | 2,731,127 | 2.7 M to 2.7 M (+0.78 %) |
| Jan 20 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.50 | 16,200 | 89,100 | 2,710,042 | 2.7 M to 2.7 M (+0.60 %) |
| Jan 17 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.50 | 17,800 | 97,900 | 2,693,842 | 2.7 M to 2.7 M (+0.67 %) |
| Jan 17 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.49 | 52,311 | 287,187 | 2,676,042 | 2.6 M to 2.7 M (+1.99 %) |
| Jan 17 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.50 | 49,776 | 273,768 | 2,623,731 | 2.6 M to 2.6 M (+1.93 %) |
| Jan 10 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | P | 0.00 | 4,865,430 | 4,865 | 4,865,430 | |
| Jan 10 2017 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 5.60 | 581,870 | 3,258,472 | 2,573,955 | 2 M to 2.6 M (+29.21 %) |
| Jan 10 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | P | 0.00 | 51,047 | 51 | 51,047 | |
| Jan 10 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | P | 0.00 | 2,341,786 | 2,342 | 2,341,786 | |
| Jan 10 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | P | 5.60 | 6,104 | 34,182 | 435,444 | 429.3 K to 435.4 K (+1.42 %) |
| Jan 10 2017 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | P | 5.60 | 280,059 | 1,568,330 | 1,037,994 | 757.9 K to 1 M (+36.95 %) |
| Oct 28 2016 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Science ... | Option Exercise | A | 5.50 | 30,000 | 165,000 | 30,000 | |
| Oct 28 2016 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Option Exercise | A | 5.50 | 30,000 | 165,000 | 30,000 | |
| Oct 05 2016 | MYG | Mirati Therapeutic ... | LEMASTERS CHRISTOPHER C. | EVP, Chief Business ... | Option Exercise | A | 6.45 | 120,000 | 774,000 | 120,000 | |
| Sep 29 2016 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Director | Option Exercise | A | 6.78 | 25,000 | 169,500 | 25,000 | |
| Jun 14 2016 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | PRESIDENT & CEO | Buy | P | 7.05 | 20,000 | 141,070 | 48,556 | 28.6 K to 48.6 K (+70.04 %) |
| Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.56 | 2,318 | 22,157 | 30,003 | 32.3 K to 30 K (-7.17 %) |
| Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.56 | 158,684 | 1,516,797 | 2,122,417 | 2.3 M to 2.1 M (-6.96 %) |
| Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.56 | 9,056 | 86,563 | 116,778 | 125.8 K to 116.8 K (-7.20 %) |
| Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.40 | 5,111 | 48,043 | 32,321 | 37.4 K to 32.3 K (-13.65 %) |
| Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.40 | 349,919 | 3,289,239 | 2,281,101 | 2.6 M to 2.3 M (-13.30 %) |
| Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.40 | 19,970 | 187,718 | 125,834 | 145.8 K to 125.8 K (-13.70 %) |
| Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.21 | 2,154 | 19,844 | 37,432 | 39.6 K to 37.4 K (-5.44 %) |
| Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.21 | 147,529 | 1,359,096 | 2,631,020 | 2.8 M to 2.6 M (-5.31 %) |
| Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.21 | 8,417 | 77,541 | 145,804 | 154.2 K to 145.8 K (-5.46 %) |
| Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.44 | 4,201 | 39,648 | 39,586 | 43.8 K to 39.6 K (-9.59 %) |
| Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.44 | 275,506 | 2,600,171 | 2,778,549 | 3.1 M to 2.8 M (-9.02 %) |
| Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.44 | 16,493 | 155,658 | 154,221 | 170.7 K to 154.2 K (-9.66 %) |
| Jun 08 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 9.49 | 161,751 | 1,535,049 | 1,992,085 | 1.8 M to 2 M (+8.84 %) |
| Jun 08 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 10.31 | 215,151 | 2,217,368 | 1,830,334 | 1.6 M to 1.8 M (+13.32 %) |
| May 19 2016 | MYG | Mirati Therapeutic ... | RINGO WILLIAM R | Director | Option Exercise | A | 15.72 | 10,000 | 157,200 | 10,000 | |
| May 19 2016 | MYG | Mirati Therapeutic ... | Johnson Craig A | Director | Option Exercise | A | 15.72 | 10,000 | 157,200 | 10,000 | |
| May 19 2016 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Director | Option Exercise | A | 15.72 | 10,000 | 157,200 | 10,000 | |
| May 19 2016 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Director | Option Exercise | A | 15.72 | 10,000 | 157,200 | 10,000 | |
| May 19 2016 | MYG | Mirati Therapeutic ... | LAPPE RODNEY W | Director | Option Exercise | A | 15.72 | 10,000 | 157,200 | 10,000 | |
| May 09 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 17.15 | 4,500 | 77,175 | 1,615,183 | 1.6 M to 1.6 M (+0.28 %) |
| May 09 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 18.29 | 61,282 | 1,120,731 | 1,610,683 | 1.5 M to 1.6 M (+3.96 %) |
| Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 6.74 | 3,479 | 23,448 | 0 | |
| Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 6.74 | 310,003 | 2,089,420 | 0 | |
| Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 6.74 | 137 | 923 | 0 | |
| Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 6.74 | 137 | 923 | 0 | |
| Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 6.74 | 3,479 | 23,448 | 43,787 | 40.3 K to 43.8 K (+8.63 %) |
| Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 6.74 | 310,003 | 2,089,420 | 3,054,055 | 2.7 M to 3.1 M (+11.30 %) |
| Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 6.74 | 137 | 923 | 137 | 0 to 137 |
| Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 6.74 | 137 | 923 | 137 | 0 to 137 |
| Mar 31 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 19.09 | 3,400 | 64,906 | 1,549,401 | 1.5 M to 1.5 M (+0.22 %) |
| Mar 28 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 19.48 | 300 | 5,844 | 1,546,001 | 1.5 M to 1.5 M (+0.02 %) |
| Mar 28 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 19.36 | 20,548 | 397,809 | 1,545,701 | 1.5 M to 1.5 M (+1.35 %) |
| Mar 23 2016 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Option Exercise | A | 20.40 | 18,750 | 382,500 | 18,750 | |
| Mar 23 2016 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Option Exercise | A | 20.40 | 1,250 | 25,500 | 1,250 | |
| Mar 22 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | P | 19.34 | 1,166 | 22,550 | 1,525,153 | 1.5 M to 1.5 M (+0.08 %) |
| Mar 17 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | J | 0.00 | 375,298 | 0 | 1,523,987 | 1.1 M to 1.5 M (+32.67 %) |
| Mar 17 2016 | MYG | Mirati Therapeutic ... | Boxer Asset Management Inc. | 10% Owner | Sell | J | 0.00 | 375,298 | 0 | 0 | 375.3 K to 0 (-100.00 %) |
| Mar 17 2016 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | J | 0.00 | 474,158 | 0 | 757,935 | 1.2 M to 757.9 K (-38.48 %) |
| Jan 26 2016 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Vice President, Fin ... | Option Exercise | A | 24.99 | 22,000 | 549,780 | 22,000 | |
| Jan 26 2016 | MYG | Mirati Therapeutic ... | CHEN ISAN | Sr. Vice President, ... | Option Exercise | A | 24.99 | 60,000 | 1,499,400 | 60,000 | |
| Jan 26 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Option Exercise | A | 24.99 | 60,000 | 1,499,400 | 60,000 | |
| Jan 26 2016 | MYG | Mirati Therapeutic ... | Christensen Jamie | Sr. Vice President, ... | Option Exercise | A | 24.99 | 60,000 | 1,499,400 | 60,000 | |
| Jan 26 2016 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 24.99 | 115,000 | 2,873,850 | 115,000 | |
| Jan 19 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Option Exercise | M | 8.50 | 10,000 | 85,000 | 117,000 | |
| Jan 19 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Option Exercise | M | 8.50 | 5,000 | 42,500 | 127,000 | |
| Jan 19 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Sell | S | 25.92 | 10,000 | 259,211 | 5,748 | 15.7 K to 5.7 K (-63.50 %) |
| Jan 19 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Buy | M | 8.50 | 10,000 | 85,000 | 15,748 | 5.7 K to 15.7 K (+173.97 %) |
| Jan 19 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Buy | M | 8.50 | 5,000 | 42,500 | 5,748 | 748 to 5.7 K (+668.45 %) |
| Jan 15 2016 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | J | 0.00 | 626,189 | 0 | 1,148,689 | 522.5 K to 1.1 M (+119.84 %) |
| Jan 15 2016 | MYG | Mirati Therapeutic ... | Boxer Asset Management Inc. | 10% Owner | Sell | J | 0.00 | 626,189 | 0 | 0 | 626.2 K to 0 (-100.00 %) |
| Jan 15 2016 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | J | 0.00 | 791,139 | 0 | 1,232,093 | 2 M to 1.2 M (-39.10 %) |
| Jan 15 2016 | MYG | Mirati Therapeutic ... | CHEN ISAN | Sr.Vice President, ... | Option Exercise | M | 15.79 | 2,542 | 40,138 | 106,792 | |
| Jan 15 2016 | MYG | Mirati Therapeutic ... | CHEN ISAN | Sr.Vice President, ... | Buy | M | 15.79 | 2,542 | 40,138 | 18,113 | 15.6 K to 18.1 K (+16.33 %) |
| Jan 05 2016 | MYG | Mirati Therapeutic ... | Berkley Capital Management Ltd ... | 10% Owner | Sell | J | 0.00 | 522,500 | 0 | 0 | 522.5 K to 0 (-100.00 %) |
| Sep 18 2015 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | S | 6.74 | 1 | 7 | 0 | |
| Sep 18 2015 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | S | 6.74 | 1 | 7 | 0 | |
| Sep 18 2015 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | P | 45.00 | 22,500 | 1,012,500 | 522,500 | 500 K to 522.5 K (+4.50 %) |
| Sep 18 2015 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | P | 45.00 | 22,500 | 1,012,500 | 2,023,232 | 2 M to 2 M (+1.12 %) |
| Sep 16 2015 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 6.74 | 137 | 923 | 137 | |
| Sep 16 2015 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 6.74 | 137 | 923 | 137 | |
| Sep 16 2015 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 6.74 | 274 | 1,847 | 0 | |
| Sep 16 2015 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 45.00 | 139,220 | 6,264,900 | 2,744,052 | 2.6 M to 2.7 M (+5.34 %) |
| Sep 16 2015 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 45.00 | 10,780 | 485,100 | 170,714 | 159.9 K to 170.7 K (+6.74 %) |
| May 27 2015 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP & Chief Scienti ... | Option Exercise | M | 17.41 | 4,750 | 82,698 | 55,250 | |
| May 27 2015 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP & Chief Scienti ... | Sell | S | 28.03 | 2,550 | 71,477 | 1,250 | 3.8 K to 1.3 K (-67.11 %) |
| May 27 2015 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP & Chief Scienti ... | Sell | S | 28.11 | 2,200 | 61,845 | 3,800 | 6 K to 3.8 K (-36.67 %) |
| May 27 2015 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP & Chief Scienti ... | Buy | M | 17.41 | 4,750 | 82,698 | 6,000 | 1.3 K to 6 K (+380.00 %) |
| May 22 2015 | MYG | Mirati Therapeutic ... | LAPPE RODNEY W | Director | Option Exercise | A | 25.84 | 15,000 | 387,600 | 15,000 |